Earnings Reports

Found 60,026 articles

• Merck Announces Fourth-Quarter 2019 Dividend

  7/23/2019

  Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.55 per share of the company’s common stock for the fourth quarter of 2019.

• Henry Schein to Webcast Second Quarter 2019 Conference Call on Tuesday, August 6, 2019 at 10:00 A.M. Eastern Time

  7/23/2019

  Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that it will release its second quarter 2019 financial results before the stock market opens on Tuesday, August 6, 2019, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time

• Gamida Cell Announces the Date of Its Second Quarter 2019 Financial Results and Webcast

  7/23/2019

  Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Tuesday, August 6, 2019, at 8:30 a.m. ET to review its second quarter 2019 financial results and provide an update on the company.

• Cellular Biomedicine Group to Report Second Quarter 2019 Results on August 6, 2019

  7/23/2019

  Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it will release its financial results for the second quarter ended June 30, 2019 after the market closes on Tuesday, August 6, 2019.

• Infinity Announces The Date Of Its Second Quarter 2019 Financial Results Conference Call And Webcast

  7/23/2019

  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, July 30, 2019 at 8:00 a.m. ET to review its second quarter 2019 financial results and provide an update on the company.

• Surmodics to Webcast Third Quarter Fiscal 2019 Earnings Conference Call on July 31

  7/23/2019

  Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2019 conference call on Wednesday, July 31, at 4 p.m. CT (5 p.m. ET).

• We Are Pleased to Announce That Tanner Pharma Group Has Been Granted Direct Access to Procure Pfizer Medicines for European Clinical Trials Including Hospira Legacy Products With All Relevant Documentation Available

  7/23/2019

  TannerCTS is a clinical trial sourcing partner focused exclusively on the global sourcing and supply of comparators, concomitant medication, ancillaries and rescue medication with over 17 years’ experience sourcing pharmaceutical products.

• Tivity Health to Issue Second Quarter 2019 Financial Results After Market Close on August 7

  7/23/2019

  Financial results for the second quarter ending June 30, 2019, will be released after market close on Wednesday, August 7, 2019, followed the same day by a conference call and live webcast scheduled for 5:00 p.m. ET.

• Titan Medical a Letter to the Shareholders from the President and CEO

  7/23/2019

  Mid-year update on Titan Medical’s progress and outlook for the remainder of the year.

• Evolent Health, Inc. to Release Second Quarter 2019 Operating Results and Host Conference Call on Tuesday, August 6, 2019

  7/23/2019

  Second quarter 2019 operating results on Tuesday, August 6, 2019 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

• Neogen reports fiscal 2019 results

  7/23/2019

   Neogen Corporation (NASDAQ: NEOG) announced today that revenues for the fourth quarter of its 2019 fiscal year, which ended May 31, were $109,762,000, compared to $108,120,000 the prior year quarter.

• Quest Diagnostics Reports Second Quarter 2019 Financial Results

  7/23/2019

  Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced financial results for the second quarter ended June 30, 2019.

• Medidata Reports Second Quarter 2019 Results

  7/23/2019

  Medidata announced its financial results for the second quarter of 2019.

• Ergomed H1 2019 Trading Update

  7/22/2019

  Revenue and EBITDA for full year 2019 expected to be ahead of market expectations

• RMS Medical Products Schedules 2019 Second Quarter Financial Results and Conference Call

  7/22/2019

  Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that it will release its financial results for the second quarter and six months ended June 30, 2019 after the close of the financial markets on Tuesday, August 6, 2019.

• Castlight Health to Announce Second Quarter 2019 Results

  7/22/2019

  Castlight Health, Inc. (NYSE: CSLT) will release its second quarter 2019 financial results on Tuesday, July 30, 2019, after the market closes

• Vanda Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019

  7/22/2019

  Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2019 on Wednesday, July 31, 2019, after the market closes.

• Cutera, Inc. to Announce Second Quarter 2019 Results

  7/22/2019

  Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, will announce financial results for the second quarter 2019 on Thursday, August 8, 2019 after market close.

• Cerus Corporation to Release Second Quarter 2019 Results on August 1, 2019

  7/22/2019

  The company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.

• Apollo Endosurgery, Inc. to Report Second Quarter Results on July 23, 2019

  7/19/2019

  Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended June 30, 2019 on Tuesday, July 23, 2019, after the U.S. stock markets close.